10 Stocks to Watch: Align, Apollo


NEW YORK (TheStreet) -- The maker of the Invisalign teeth straightening system, Align Technology (ALGN) ended Wednesday's trading session down 3.8% to $20.37 after agreeing to acquire dentistry imaging company Cadent for $190 million.


Apollo Global Management ( APO) fell 4.2% to $18.20 following rousing reception of the private-equity firm's long-awaited initial public offering Tuesday. On Wednesday, Thomson Reuters releases data highlighting mixed IPO results from Apollo's portfolio companies.
>> Apollo's IPO Gets Warm Reception


Palo Alto, Calif.-based cloud computing application maker Tibco Software ( TIBX) rose 1.8% at $26.74 after edging past Wall Street's expectations for its fiscal first-quarter results. While Tibco's performance was ahead of the consensus view, the magnitude of the beat was only 5% vs. a 16% average beat in the previous eight quarters.
>> Tibco Software: After-Hours Trading


Wal-Mart ( WMT) rose 0.2% to $52.36 after a visiting positive territory as judges expressed skepticism about a large class-action lawsuit against the giant retailer over sex discrimination.


Phosphate and potash company Mosaic ( MOS) ended up 2% to $80.45 ahead of its third-quarter earnings report after the markets close Wednesday.


Chemicals company DuPont ( DD) added 1.4% to $55.37 after its subsidiary DuPont Denmark extended a $6 billion offer for food ingredients company Danisco to April 29 to allow for additional time to obtain regulatory approvals in the European Union and China. So far, shareholders representing a mere 6% stake in Danisco have accepted DuPont's offer, 90% short of the acceptances the buyer would have needed to meet its original offer closing date of April 1.


Drug company Cephalon ( CEPH) is facing a hostile bid from Valeant Pharmaceuticals ( VRX), which is offering $73 a share, a 24% premium to Cephalon's closing price Tuesday of $58.75.

Cephalon shares surged 28.4% to $75.44 Wednesday.

Shares of Valeant popped 12.8% to $50.08.
>> Valeant Goes Hostile With Cephalon Bid


Investment manager BlackRock ( BLK) advanced 6.6% to $198.84 as it replaces biotech company Genzyme ( GENZ) in the S&P 500 after the markets close on Friday.


Discount store chain Family Dollar ( FDO) fell 0.3% to $52.25 as investors took profits after the company reported second-quarter earnings of 98 cents a share. The earnings beat narrowly expectations by a penny.

>>Search for Highest Dividends by Rate or Yield
More on Earnings
Today's Top Earnings
Earnings Calendar

-- Written by Andrea Tse in New York.

>To contact the writer of this article, click here: Andrea Tse.

>To follow the writer on Twitter, go to Andrea Tse.

>To submit a news tip, send an email to: tips@thestreet.com.

Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More from Opinion

4 Potential Reasons Why Netflix Missed Its Subscription Guidance

4 Potential Reasons Why Netflix Missed Its Subscription Guidance

Tuesday Turnaround: Model 3's Profitable, Netflix Sinks and Goldman's Got Beats

Tuesday Turnaround: Model 3's Profitable, Netflix Sinks and Goldman's Got Beats

3 Things to Watch When Microsoft Reports Earnings on Thursday

3 Things to Watch When Microsoft Reports Earnings on Thursday

Netflix Tanks on Disappointing Subscriber Numbers: 10 Key Takeaways

Netflix Tanks on Disappointing Subscriber Numbers: 10 Key Takeaways

Tesla's Elon Musk Must Realize He Can't Do It All: Dumbest Thing on Wall Street

Tesla's Elon Musk Must Realize He Can't Do It All: Dumbest Thing on Wall Street